Skip to main content

Dexcom

Dexcom Inc is an American medical device company that designs, develops, and commercializes continuous glucose monitoring systems for people living with diabetes. The company's main products consist of wearable sensors and transmitters that measure glucose levels in real time, transmitting data wirelessly to mobile applications or dedicated receivers. Its primary revenue drivers are the recurring sales of disposable sensors, transmitters, and related software platforms used by individuals with type 1 and type 2 diabetes. The end market primarily comprises the global healthcare sector, with distribution flowing through pharmacies, medical equipment suppliers, and direct-to-consumer channels reimbursed by commercial and government insurers. Dexcom holds a major global market position in continuous glucose monitoring technology alongside competitors in the diabetes care industry. The company is headquartered in San Diego, California, and its common stock is publicly listed on the Nasdaq Stock Market under the ticker symbol DXCM.

60 of the funds FundTelligence covers report a position in Dexcom.

Legal name
Dexcom Inc.
Sector
Health Care
Country
United States
Funds holding it
60
Exposure themes
Diabetes Technology, Glucose monitoring, Glucose Monitoring, Monitoring and disease management, Obesity & Metabolic Health, Women's Health

Funds holding Dexcom

Showing the 8 largest of 60 funds holding it.

Loading...